April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Immunoproteomic Analysis of Serum Antibody Complexes in Glaucoma Patients
Author Affiliations & Notes
  • Melissa G. Tong
    Ophthalmology & Visual Sciences,
    University of Louisville, Louisville, Kentucky
  • Xiangjun Yang
    Ophthalmology & Visual Sciences,
    University of Louisville, Louisville, Kentucky
  • Cheng Luo
    Ophthalmology & Visual Sciences,
    University of Louisville, Louisville, Kentucky
  • Jian Cai
    Pharmacology & Toxicology,
    University of Louisville, Louisville, Kentucky
  • Powell W. David
    Biochemistry & Molecular Biology,
    University of Louisville, Louisville, Kentucky
  • Joern B. Soltau
    Ophthalmology & Visual Sciences,
    University of Louisville, Louisville, Kentucky
  • Jeffrey M. Liebmann
    Einhorn Clinical Research Center, New York Eye & Ear Infirmary, New York, New York
  • Robert Ritch
    Einhorn Clinical Research Center, New York Eye & Ear Infirmary, New York, New York
  • Gulgun Tezel
    Pharmacology & Toxicology,
    Anatomical Sciences & Neurobiology,
    University of Louisville, Louisville, Kentucky
  • Footnotes
    Commercial Relationships  Melissa G. Tong, None; Xiangjun Yang, None; Cheng Luo, None; Jian Cai, None; Powell W. David, None; Joern B. Soltau, None; Jeffrey M. Liebmann, None; Robert Ritch, None; Gulgun Tezel, None
  • Footnotes
    Support  NEI grants (R01 EY013813, R01 EY017131, R24 EY015636), and RPB
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2431. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Melissa G. Tong, Xiangjun Yang, Cheng Luo, Jian Cai, Powell W. David, Joern B. Soltau, Jeffrey M. Liebmann, Robert Ritch, Gulgun Tezel; Immunoproteomic Analysis of Serum Antibody Complexes in Glaucoma Patients. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2431.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Glaucoma patients exhibit increased titers of serum antibodies to retina and optic nerve proteins. As part of studies exploring the regulation of immune response in glaucoma, this study aimed to identify disease-related antigens in serum IgG complexes.

Methods: : Serum samples were collected from 142 patients with high- or normal-pressure primary open-angle glaucoma or pseudoexfoliative glaucoma, and 70 control subjects without glaucoma. Serum protein complexes containing IgG were eluted using co-immunoprecipitation and spin-column purification, and were quantitatively analyzed by 2D-LC-MS/MS. For further validation, serum samples were also traditionally tested against human retinal proteins and recombinant proteins using Western blot analysis followed by 2D-LC-MS/MS for protein identification. Oxidized proteins containing reactive carbonyl groups were determined by 2D-oxyblot analysis and ELISA.

Results: : Quantitative 2D-LC-MS/MS analysis of the IgG-containing protein mixtures revealed a complex profile, which included proteins with potential relevance to glaucomatous retina as well as seemingly irrelevant proteins localized elsewhere. Proteins identified in serum IgG complexes included stress proteins, structural proteins, and mitochondrial enzymes that were previously presented as glaucoma-related antigens. Immunoproteomic analysis also identified many new antigens with high confidence (based on at least two identified peptide and a greater than 99.0% probability assigned by the Protein Prophet algorithm). These included different isoforms of neural cell adhesion molecule, integrin, annexin, dynein, CREB-binding protein, calmodulin-regulated spectrin, ubiquitin-protein ligase, and apoptosis-inducing factor 1. Glaucomatous samples exhibited greater levels of protein carbonyls (p<0.01), and most of the proteins identified in serum IgG complexes were oxidatively modified.

Conclusions: : Using a new immunoproteomic approach, this study identified various proteins in the serum IgG complexes sampled from different subtypes of glaucoma. Based on the findings that the antigenic proteins were oxidatively modified and included both neuronal and non-neuronal proteins, increased serum antibodies are likely a consequence of the disease and represent the immune system-driven tissue cleaning/healing process. Ongoing studies should determine whether increased serum antibodies also reflect the molecular imprint of disease-causing antigens.

Keywords: proteomics • immunomodulation/immunoregulation • neuroprotection 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×